Desmoda: FDA Approves the First and Only Liquid Version of Desmopressin to Ensure Precise Dosing in Patients With Central Diabetes Insipidus

Medically Reviewed by Francisco Talavera, PharmD, PhD on February 26, 2026

The FDA has approved Desmoda (desmopressin acetate) oral solution for managing central diabetes insipidus (CDI) in adults and children. It is a liquid version of a lab‑made form of vasopressin, a natural antidiuretic hormone.

CDI (also known as arginine vasopressin deficiency) is an uncommon but serious disorder. It is caused by the insufficient production of vasopressin from the hypothalamus/posterior pituitary in the brain, leading the body to make large volumes of dilute urine and creating intense thirst.

Desmoda works by acting on V2 receptors in the kidneys, which regulate how much water gets reabsorbed by the kidneys. This mechanism controls whether the urine becomes dilute or concentrated. By adjusting this process, Desmoda helps maintain the body's water balance and keeps it properly hydrated.

This approval matters because Desmoda is the first and only FDA‑approved liquid version of desmopressin that can be taken orally. A ready‑to‑use liquid makes it easier to make small dose adjustments over time, without the need for cutting or crushing tablets. Although desmopressin is for standard care, your dose will often require frequent and careful adjustments to prevent under‑ or overtreatment. The oral liquid medication gives you and your health care provider greater flexibility to fine‑tune dosing as your needs change.

Desmoda should not be used for treating nephrogenic diabetes insipidus, which is caused by kidney issues instead of low vasopressin levels.

The FDA's decision relied on research-based evidence that oral desmopressin provides meaningful antidiuretic effects in patients with CDI.

In clinical dose-response studies involving patients with CDI, a range of doses of desmopressin acetate tablets (0.025 mg to 0.4 mg) produced significant antidiuretic effects, reducing urine output. The antidiuretic effect typically began about an hour after a dose and peaked between four and seven hours. Higher doses tended to prolong the effect, which lasted up to eight hours.

Desmoda oral solution was assessed in studies that showed it works the same way in the body as FDA-approved desmopressin tablets. In a clinical study with healthy adults, researchers found that Desmoda was absorbed at a similar speed and amount as the reference medicine.

These results show that Desmoda can be used as an alternative to desmopressin tablets. The liquid form also allows for more precise and adjustable dosing, making it suitable for patients of all ages.

Common side effects include headaches, dizziness, stomach pain, high blood pressure, and diarrhea. Serious adverse effects include hyponatremia (low blood sodium levels), fluid buildup, allergic reactions, and a risk of death in infants with a low birth weight or those born prematurely who have received IV medicines containing benzyl alcohol. Other side effects that have been reported include nausea, vomiting, tiredness, swelling from water intoxication (too much water in the body), seizures, confusion, hallucinations, difficulty emptying the bladder, and skin rashes.

The usual starting dose is 0.05 mg, to be taken by mouth twice a day on an empty stomach at least one hour before or two hours after food. Use an oral syringe from the pharmacy to measure every dose. If you or your child is switching from Desmoda nasal spray, wait 12 hours after your last spray before starting the liquid version. Your health care provider may adjust your or your child's dose, check your or child's urine output, and do other lab tests to see how you or your child is responding.

Discuss how much fluid you or your child should take while taking Desmoda with your health care provider. It is important to strictly follow their recommended limits and avoid drinking excessive fluids during the course of treatment as it may lead to water intoxication, hyponatremia, or even death. Your health care provider may check your sodium levels more often if you or your child has conditions or takes medicines that increase this risk.

Before you take Desmoda, be sure to tell your health care provider about all medical conditions, especially if you or your child has had hyponatremia in the past or has it currently, has moderate to severe kidney problems, has a history of difficulty emptying the bladder, has heart or blood circulation problems or hard-to‑control high blood pressure, is at a risk of high pressure in the skull, or has a known allergy to desmopressin or any of its ingredients.

Let your health care provider know about all the prescription and over-the-counter medicines, vitamins, and herbal supplements you take. Taking Desmoda with other vasoconstrictors may raise blood pressure and may require a change in dose.

Your health care provider may temporarily stop Desmoda during illnesses involving vomiting, diarrhea, or fever, or during very hot weather or intense exercise when your or your child's fluid and salt balance can change quickly.

It is not known whether Desmoda can harm your fetus. Be sure to tell your health care provider if you are pregnant or planning to become pregnant. Also, let them know if you are breastfeeding or plan to breastfeed, as the medicine can pass into your breast milk. Talk to your health care provider about the best way to feed your baby if you take Desmoda.

The product contains benzoic acid, which is produced when benzyl alcohol breaks down. In infants with a low birth weight or those born prematurely, exposure to benzyl alcohol‑related substances can cause serious harm. Use extra caution and monitor these infants closely.

Contact your health care provider right away if you or your child has headaches, nausea, vomiting, weight gain, muscle spasms, cramps, weakness, hallucinations, confusion, crankiness, or restlessness. These could be signs of serious side effects.

The drug company expects a U.S. launch in early March.

Add WebMD as a Preferred Source to see more of our trusted content across Google Search, AI Overviews, and AI Mode